3rd REAL Africa – Infections series: HBV infection and liver transplantation
For ILTS members only, please join now or renew your membership.
- Introduction of the REAL Webinar Initiative – Iman Fawzy Montasser and Wendy Spearman
- Use of HBV donors in liver transplantation – Marina Berenguer
- Prevention of Hepatitis B recurrence post liver transplantation (including the use of HB IgG core positive donors) – Mark Sonderup
- Q&A moderated by Alexandra Shingina and James Fung
- Closing Remarks
Iman Fawzy Montasser
Iman Fawzy Montasser is a Professor of Tropical Medicine and Hepatology at Ain Shams University, she is a Transplant Hepatologist and Physician Scientist in Ain Shams Center for Organ Transplantation (ASCOT) since 2008 till now. Special research interest in viral hepatitis, Hepatocellular carcinoma (HCC), immunosuppression and living donor liver transplantation (LDLT). She has published more than 50 peer-reviewed international publications on gastrointestinal and liver diseases in scientific journals and is a reviewer for many international journals. She is a member of the African Society of Organ transplantation (ASOT), The Transplantation Society (TTS) and Diversity, equality and inclusion (EDI) Committee of the International Liver Transplantation Society (ILTS).
Wendy Spearman is Head of the Division of Hepatology, Department of Medicine, Faculty of Health Sciences at the University of Cape Town. She is Head of the Liver and Liver Transplant clinics at Groote Schuur Hospital. She completed her 2-year Hepatology Fellowship under Professors Ralph Kirsch and Simon Robson at the UCT/MRC Liver Research Centre in 1991 and obtained her PhD in 2008 from the University of Cape Town on “The effect of two novel C-type lectins, Ba100 and Ba25, isolated from the venom of the puff adder, Bitis arietans on T lymphocyte proliferative responses.”
Marina Berenguer is a Consultant Hepatologist at La Fe University Hospital in Valencia, Spain, where she is head of the Hepatology and Liver Transplantation Unit. She is also a Full Professor of Medicine at the University of Valencia, Faculty of Medicine, Past President of the International Liver Transplant Society, Research Coordinator within a National Network Research Center in Hepatology, CIBER-EHD, and Coordinator of La Fe University Research Group “Hepatology, Hepatobiliopancreatic surgery, and Transplantation”.
Mark Sonderup graduated MBChB from the University of Cape Town in 1995. He completed postgraduate training at the University of Cape Town and Groote Schuur Hospital in 2002. A 2-year fellowship in Hepatology at the UCT/Medical Research Council Liver Research Centre and Liver Clinic at Groote Schuur Hospital, Cape Town was completed in 2004. He is currently Associate Professor in the Department of Medicine and Division of Hepatology. He is both a general and transplant hepatologist. Research interest include viral hepatitis, HIV associated liver disease and drug induced liver injuries.
Dr. Alexandra Shingina completed undergraduate and medical school at McGill University, followed by her Internal Medicine Residency at the University of British Columbia in Canada, where she served as Chief Resident She completed her Gastroenterology Fellowship at the University of Toronto where she received a Master’s in Clinical Epidemiology. After completing her Transplant Hepatology Fellowship at the University of Washington, Dr. Shingina was recruited by Vanderbilt University Medical Center (VUMC) in 2019 as an Assistant Professor of Medicine on the Clinical Educator Track. Dr. Shingina is interested in translational and clinical outcome research surrounding combined heart/liver transplantation (CHLT) and living donor liver transplantation (LDLT).
James Fung, MD, is a Consultant and Honorary Associate Professor in the Division of Gastroenterology and Hepatology, Department of Medicine; and at the Division of Liver Transplantation, Department of Surgery at Queen Mary Hospital, Hong Kong. He received his primary medical degree and subsequently his Doctor of Medicine from the University of Auckland, New Zealand. He completed his specialist training at Auckland City Hospital and Middlemore Hospital. With a particular interest in transplant hepatology, he spent one year training at the New Zealand Liver Transplant Unit. Dr. Fung moved to Hong Kong in 2005 and now serves as the only dedicated transplant hepatologist in the region.